Cellectis S.A. American Depositary Shares (CLLS) is a publicly traded Healthcare sector company. As of May 21, 2026, CLLS trades at $3.66 with a market cap of $387.35M and a P/E ratio of 0.00. CLLS moved +0.83% today. Year to date, CLLS is -19.38%; over the trailing twelve months it is +137.66%. Its 52-week range spans $1.10 to $5.48. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces CLLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cellectis S.A. American Depositary Shares (CLLS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CLLS moved +0.83% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $3.66 |
| Market Cap | $387.35M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.48 |
| 52-Week Low | $1.10 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover CLLS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.